Social media

A 2025 ICON survey reflected the persistent use of conventional trial formats for emerging obesity drugs with multi-indication potential. However, nontraditional trial formats can be better suited to multi-indication dev...

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Zhang, our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disea...

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Zhang, our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disea...

What does successful biomarker integration look like in early-phase CNS trials? Discover how leading researchers are applying imaging, wet, genetic, and digital biomarkers to enrich populations and improve decision-maki...

One billion people worldwide will be living with obesity by 2030. Connect with us at Obesity Week, booth #520 on Nov 4–7 to learn how ICON supports obesity trials with market intelligence, regulatory expertise, and ready...

Meet ICON at #ObesityWeek, Nov 4–7 at booth \#520 to arrange time with our experts and explore how we support next-gen obesity trials. From proof of concept to large portfolios, ICON delivers market intelligence and read...

ICON invites you to attend a presentation by Arjen Akkerman, Senior Director, Accelerated Pharmaceutical Solutions on 28 October at 11:35 am at Messe Frankfurt. In his session, “From collaboration to commitment: Strengt...

ICON invites you to attend a presentation by Arjen Akkerman, Senior Director, Accelerated Pharmaceutical Solutions on 28 October at 11:35 am at Messe Frankfurt. In his session, “From collaboration to commitment: Strengt...

This October, ICON will be in Copenhagen as a proud sponsor of the #OCTNordics conference, taking place on the 21st and 22nd. We invite you to stop by booth #41 to meet our team and discover how ICON is partnering with ...

This October, ICON will be in Copenhagen as a proud sponsor of the #OCTNordics conference, taking place on the 21st and 22nd. We invite you to stop by booth \#41 to meet our team and discover how ICON is partnering with...

Meet ICON’s experts at #ESMO25, booth #3034 to discuss how our extensive testing capabilities, clinical research experience and scientific expertise can support global oncology and haematology research programmes. https:...

Meet ICON’s experts at #ESMO25, booth \#3034 to discuss how our extensive testing capabilities, clinical research experience and scientific expertise can support global oncology and haematology research programmes. https...